Skip to main content

Table 4 General characteristics of study subjects by different AGEs levels.

From: Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients

 

AGE 2.0 (N = 193)

AGE > 2.0 (N = 188)

 

Males(N = 88)

Females(N = 105)

Males(N = 64)

Females(N = 124)

 

Mean

±

S.D

Mean

±

S.D

Mean

±

S.D

Mean

±

S.D

Age(yrs)

65.6

±

8.9

63.3

±

7.4

63.8

±

8.8

63.4

±

6.9

Weight(kg)

67.9

±

9.3***b

60.5

±

9.8x

72.8

±

8.5***

63.3

±

9.8

BMI(kg/m2)

24.8

±

2.9b

25.2

±

3.8x

26.3

±

3.0

26.3

±

3.8

Glucose(mg/dL)

147.0

±

46.4

148.5

±

47.5

147.5

±

47.7

156.0

±

51.3

HbAlc(%)

8.1

±

1.6

8.3

±

1.6x

8.1

±

1.5*

8.8

±

1.8

CHOL(mg/dL)

170.4

±

36.5***a

189.2

±

32.9z

185.3

±

40.0**

206.9

±

41.8

TG(mg/dL)

110.0

±

64.0c

119.7

±

56.8z

226.0

±

109.4

202.2

±

92.5

HDL-C(mg/dL)

47.5

±

10.5***c

58.8

±

12.9z

41.1

±

8.6***

51.5

±

12.7

LDL-C(mg/dL)

113.6

±

29.5

120.4

±

30.6x

117.3

±

36.4*

132.4

±

39.7

CHOL/HDL-C

3.7

±

1.2*c

3.3

±

0.8z

4.7

±

1.1*

4.3

±

1.2

LDL-C/HDL-C

2.5

±

1.0*b

2.2

±

0.7z

3.0

±

0.9

2.7

±

1.0

TG/HDL-C

2.6

±

1.8c

2.2

±

1.2z

5.7

±

3.4**

4.4

±

2.5

AI

5.8

±

1.4c

5.8

±

1.5z

7.8

±

1.7

7.4

±

2.0

AI distribution

n (%)

n (%)

n (%)

n (%)

   0-4 (n = 119)

46(46.5)***

55(43.7)***

3(5.7)

15(14.6)

   5-8 (n = 190)

46(46.5)

59(46.8)

30(56.6)

55(53.4)

   9-12 (n = 72)

7(7.1)

12(9.5)

20(37.7)

33(32.0)

  1. * p < 0.05, ** p < 0.01, *** p < 0.001 when compared by gender.
  2. ap < 0.05bp < 0.01cp < 0.001when compared with different statuses in males
  3. xp < 0.05yp < 0.01zp < 0.001 when compared with different statuses in females
  4. BMI: body mass index; AGEs: advanced glycation end products; HbA1c: hemoglobin A1c; CHOL: cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; AI: atherosclerotic index